Prevalence and risk factors associated with multidrug-resistant bacteria in COVID-19 patients
Abdu Aldarhami,Ahmed A. Punjabi,Abdulrahman S. Bazaid,Naif K. Binsaleh,Omar W. Althomali,Subuhi Sherwani,Omar Hafiz,Ali A. Almishaal
DOI: https://doi.org/10.1097/md.0000000000037389
IF: 1.6
2024-03-09
Medicine
Abstract:Coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has ravaged millions of lives globally due to its severe symptoms and associated complications, especially among immunocompromised patients. [ 1 ] On June 19, 2023, about 87,159,156 cases and 6431,700 deaths due to COVID-19 have been reported worldwide. [ 2 ] Thus, all nations impacted by this viral infection have experienced the aftermath as a consequence. Nevertheless, the Kingdom of Saudi Arabia (KSA) will be the main focus area for this study, which till date has reported about 810,394 incidences and 9255 deaths (June 19, 2023). [ 2 , 3 ] Victims of this pandemic often experience mild symptoms including fever, cough, fatigue, and loss of smell and taste. [ 4 ] In addition, sore throat, headache, diarrhea or eye irritation or pain were also reported as clinical signs of COVID-19. [ 5 ] However, in severe cases, patients may experience serious chest pain, loss of mobility, and shortness of breath (hypoxia). [ 4 ] Nonetheless, a previous study in Saudi Arabia reported that old age, being a male, the presence of comorbidities, chronic respiratory diseases and cardiovascular illness are independent risk factors that heighten the severity of COVID-19 cases and its associated complications and deaths. [ 6 ] Thus, individuals with underlying medical conditions such as obesity, diabetes, stroke, asthma, and chronic kidney diseases are at a higher risk of being seriously ill (severe symptoms and complications), hospitalized, and dead when infected by SARS-CoV-2. [ 7 ]
medicine, general & internal